Answers are grounded in this paper and cite their sources.
Purpose: This study evaluates the patterns of failure in patients with differentiated thyroid cancer. It identifies clinicopathologic features and biomarkers, such as microvessel density (MVD) and microlymphatic vessel density (MVLD), associated with recurrence and disease-free survival. Methodology: In this single-center retrospective cohort study, patients who underwent total thyroidectomy with or without neck node dissection for differentiated thyroid carcinoma between 2011 and 2020 were included. Patterns of failure, along with clinicopathologic factors associated with recurrence, were also analyzed. MVD and MVLD were assessed in a subset of patients who had nodal and/or distant metastasis and compared to those who did not. Results: A total of 358 patients were evaluated. A multivariate analysis showed that the risk of recurrence in patients with pT4 tumors was significantly higher (hazard ratio (HR) 16.18, 95% confidence interval (CI) (1.01–55.91). Patients with N1b disease were also at a significant risk for nodal recurrence (HR 4.09, 95% CI (3.7–16.54). Positive correlation for MVD (measured number of vessels/×20 field taken as an average of five fields) was seen in patients with recurrence (71.11 vs. 63.87), tumors showing lymphovascular invasion (LVI) (74.92 vs. 65.66), and distant metastasis (72.51 vs. 64.88). However, these differences were not statistically significant. Conclusion: Factors associated with recurrence in differentiated thyroid carcinoma were pT4 disease, N1b disease and those who had received a higher dose of radio-iodine ablation. Higher MVD and MVLD in the primary tumor did not predispose to the risk of local or distant recurrence.
No takes yet. Share an insight, caveat, or question.
Sanyal et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: